Search

Displaying results 4071 - 4080 of 10000 in total
  1. Drug

    Tetracycline

    go.drugbank.com/drugs/DB00759
    ApprovedInvestigationalVet approvedWithdrawn

    The FDA withdrew its approval for the use of all liquid oral drug products formulated for pediatric use containing tetracycline in a concentration greater than 25 mg/ml. … It exerts a bacteriostatic effect on bacteria by binding reversible to the bacterial 30S ribosomal subunit and blocking incoming aminoacyl tRNA from binding to the ribosome acceptor site.

  2. Drug

    Hematoxylin

    go.drugbank.com/drugs/DB16871
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  3. Drug

    Efloxate

    go.drugbank.com/drugs/DB13333
    Experimental

    Categories: Vasodilators Used in Cardiac Diseases
  4. Drug

    Trolnitrate

    go.drugbank.com/drugs/DB13719
    Experimental

    Categories: Vasodilators Used in Cardiac Diseases
  5. Drug

    Malachite Green

    go.drugbank.com/drugs/DB03895
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  6. Drug

    Indole-3-Glycerol Phosphate

    go.drugbank.com/drugs/DB04143
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  7. Drug

    Bromopyruvate

    go.drugbank.com/drugs/DB17135
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  8. Drug

    Riferminogene pecaplasmid

    go.drugbank.com/drugs/DB06394
    Investigational

    Riferminogene pecaplasmid (non-viral fibroblast growth factor 1; NV1FGF) is a recombinant DNA plasmid in a pCOR backbone allowing expression of human FGF1.

  9. Drug

    DP-VPA

    go.drugbank.com/drugs/DB05821
    Investigational

    DP-VPA is D-Pharm's proprietary lipid modified version of valproic acid (VPA) that demonstrate that DP-VPA is well-tolerated in patients with resistant epilepsy and has a marked effect on reducing seizure

  10. Drug

    CEP-1347

    go.drugbank.com/drugs/DB05403
    Investigational

    CEP-1347 is a semi-synthetic compound shown to protect multiple nerve cell types from a variety of insults leading to programmed cell death (apoptosis) which could improve the survival of dopamine neurons